Drugs / Beriplex P/N (Kcentra)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02740335 Comparator | Jun 2017 → Feb 2022 | — | Octapharma | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beriplex P/N (Kcentra) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02740335 ↗ |
| Route | Intravenous | “administered by intravenous infusion” NCT02740335 ↗ |